LNCaP公司
前列腺癌
脂解
脂肪组织
癌症研究
对氯苯丙胺
雄激素受体
前列腺
内分泌学
脂肪细胞
内科学
医学
脂滴包被蛋白
白色脂肪组织
雄激素
肿瘤进展
肿瘤微环境
化学
细胞生长
CD44细胞
细胞
前列腺切除术
脂肪生成
脂肪生成
雄激素剥夺疗法
过氧化物酶体增殖物激活受体
细胞周期
作者
Shiting Zhao,Yuang Wei,Jiexiang Zhang,Yang Chen,Lei Li,Qiaoyun Long,Ping Gu,Sun Wei,Zhaoxi Zhang,Sharon Keying Ma,Shiqing Liang,Ziyu Zhao,Qing Liu,Mengyuan Xie,Jiayu Zhao,Yifan Zhao,Yi He,Tao Nie,Bin Lu,Jiaqing Shao
标识
DOI:10.1002/advs.202523148
摘要
Periprostatic adipose tissue (PPAT), a specialized fat depot surrounding the prostate gland, is linked to poor prostate cancer (PCa) prognosis. However, the mechanisms underlying the crosstalk between PPAT and PCa progression remain poorly understood. We found that PCa tumors, particularly aggressive ones, actively stimulated androgen receptor (AR) expression in PPAT, with elevated AR expression and signaling in PPAT being associated with aggressive PCa. Adipocyte-specific AR overexpression was sufficient to promote PCa growth in vitro and in vivo. Mechanistically, AR directly suppressed the E3 ligase RNF213, and RNF213 depletion increased hormone-sensitive lipase (HSL) protein abundance. Consequently, AR-driven lipolysis liberated free fatty acids (FFA) and promoted PCa cell growth and tumor microenvironment remodeling. Clinically, PPAT in high-risk PCa patients exhibited elevated lipolytic activity and reduced RNF213 expression. The PPAT conditioned medium (CM) of high-risk PCa patients enhanced PCa cell proliferation, which was reversed by blocking fatty acid uptake. Targeting this axis with the antilipolytic drug Acipimox significantly attenuated PCa growth in vivo. Our findings support a feed-forward interaction between prostate tumors and adipocyte AR signaling that promotes disease progression. This self-reinforcing cycle accelerates disease progression, and targeting PPAT lipolysis may represent a promising therapeutic strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI